Postnatal steroids: still a dilemma for neonatologists and parents?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding None declared.
Competing interests The author is a consultant to Chiesi Farmaceutici, Parma, Italy, a company that makes budesonide but it did not contribute in any way to this article. The author is also joint editor-in-chief of Neonatology and Chair of the Trial Steering Committee of Minidex.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.